Satellos Bioscience Inc (MSCL) Cash Flow Statement

1.140
+0.070+6.54%

15min DelayTrading Jan 23 10:17 ET

211.48MMarket Cap3.83P/E (TTM)

Satellos Bioscience Inc (MSCL) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-27.42%-4.13M

-13.21%-4.84M

-33.42%-7.37M

-99.27%-17.4M

-111.48%-4.36M

-13.77%-3.24M

-45.36%-4.28M

-527.54%-5.52M

-110.03%-8.73M

-142.05%-2.06M

Net income from continuing operations

12.12%-5.82M

-26.76%-5.61M

-19.71%-6.14M

-63.47%-19.58M

33.27%-3.4M

-162.95%-6.62M

-41.31%-4.42M

-316.50%-5.13M

-43.57%-11.98M

-35.12%-5.1M

Operating gains losses

238.24%115K

-183.21%-388K

99.43%-3K

-185.13%-1.02M

-126.89%-388.2K

102.96%34K

-115.28%-137K

-23,725.41%-524K

6,373.96%1.19M

--1.44M

Depreciation and amortization

50.00%3K

--0

-50.00%1K

164.10%13.94K

396.50%7.94K

-7.80%2K

159.78%2K

170.52%2K

-97.87%5.28K

-85.97%1.6K

Asset impairment expenditure

----

--2.76M

---145.09K

----

--0

Remuneration paid in stock

377.78%774K

60.38%834K

15.47%642K

-9.95%1.47M

-64.91%234.28K

-69.81%162K

84.22%520K

274.15%556K

54.10%1.64M

251.13%667.6K

Other non cashItems

----

-354.85%-340.02K

--12.98K

---39K

---121K

---193K

229.34%133.42K

----

Change In working capital

149.38%803K

370.34%319K

-703.88%-1.87M

-356.76%-714.19K

-187.33%-686.19K

-1.52%322K

88.60%-118K

-215.79%-232K

-61.91%278.15K

37.32%785.77K

-Change in receivables

-103.10%-18K

309.72%151K

144.55%98K

87.69%-29.96K

-83.17%-317.96K

14,179.98%580K

67.10%-72K

-251.82%-220K

-223.76%-243.48K

-395.02%-173.59K

-Change in prepaid assets

140.26%31K

164.65%128K

-2,464.29%-1.08M

-2,038.66%-1.64M

-2,258.14%-1.33M

-72.08%-77K

-1,462.14%-198K

-536.99%-42K

-5,117.64%-76.89K

-692.85%-56.29K

-Change in payables and accrued expense

536.46%790K

-73.68%40K

-3,053.33%-886K

60.42%960.15K

-5.56%959.15K

-149.23%-181K

118.30%152K

-34.55%30K

11.89%598.52K

69.90%1.02M

Cash from discontinued investing activities

Operating cash flow

-27.42%-4.13M

-13.21%-4.84M

-33.42%-7.37M

-99.27%-17.4M

-111.48%-4.36M

-13.77%-3.24M

-45.36%-4.28M

-527.54%-5.52M

-104.95%-8.73M

-115.93%-2.06M

Investing cash flow

Cash flow from continuing investing activities

-218.17%-15.33M

325.94%8.47M

133.40%4.42M

30.51%-9.18M

179,689.44%12.97M

37,754.90%1.99M

-1.37M

-597,984.67%-13.22M

-78,723,875.03%-13.21M

Net PPE purchase and sale

---3K

0.00%-3K

--0

69.19%-4.18K

82.99%-180.6311

--0

43.21%-3K

---1K

-513.84%-13.57K

-6,230.48%-1.06K

Net investment purchase and sale

-218.15%-15.33M

325.45%8.48M

--0

133.47%4.42M

30.51%-9.18M

--12.97M

--1.99M

---1.37M

---13.21M

Cash from discontinued investing activities

Investing cash flow

-218.17%-15.33M

325.94%8.47M

--0

133.40%4.42M

30.51%-9.18M

179,689.44%12.97M

37,754.90%1.99M

---1.37M

-597,984.67%-13.22M

-78,723,875.03%-13.21M

Financing cash flow

Cash flow from continuing financing activities

311.76%700K

11,500.00%1.39M

-2.31%37.27M

6,044.41%37.08M

106.83%170K

-99.97%12K

1,765.70%38.15M

5,703.15%603.55K

Net issuance payments of debt

----

--0

---284.94K

---76.01K

Net common stock issuance

----

21.87%29.82M

4,966.10%29.82M

--0

----

1,096.82%24.47M

5,560.15%588.68K

Proceeds from stock option exercised by employees

311.76%700K

11,500.00%1.39M

--2K

-46.17%7.44M

2,082.96%7.26M

148.97%170K

--12K

--0

--13.83M

--332.65K

Cash from discontinued financing activities

Financing cash flow

311.76%700K

11,500.00%1.39M

--2K

-1.96%37.27M

7,788.20%37.08M

106.83%170K

-99.97%12K

--0

1,759.18%38.01M

4,420.28%470.13K

Net cash flow

Beginning cash position

434.35%38.22M

238.11%32.71M

140.23%40.07M

960.15%15.38M

-46.68%17.36M

-80.55%7.15M

338.55%9.68M

1,072.70%16.68M

-59.59%1.45M

1,322.31%32.56M

Current changes in cash

-289.36%-18.76M

320.51%5.02M

-6.88%-7.36M

51.18%24.28M

259.05%23.54M

285.41%9.91M

-106.43%-2.28M

-977.53%-6.89M

859.23%16.06M

-1,657.22%-14.8M

Effect of exchange rate changes

-150.82%-155K

296.75%484K

102.59%3K

159.13%518.4K

149.51%575.4K

-73.99%305K

72.23%-246K

-7,745.08%-116K

-1,465.56%-876.68K

-1,948.55%-1.16M

End cash Position

11.18%19.3M

434.35%38.22M

238.11%32.71M

141.52%40.18M

-46.68%17.36M

-80.55%7.15M

338.55%9.68M

1,073.39%16.63M

Free cash from

-27.52%-4.13M

-13.20%-4.85M

-33.39%-7.37M

-99.01%-17.41M

-111.38%-4.37M

-13.48%-3.24M

-45.20%-4.28M

-527.65%-5.52M

-105.16%-8.75M

-116.03%-2.07M

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-27.42%-4.13M	-13.21%-4.84M	-33.42%-7.37M	-99.27%-17.4M	-111.48%-4.36M	-13.77%-3.24M	-45.36%-4.28M	-527.54%-5.52M	-110.03%-8.73M	-142.05%-2.06M
Net income from continuing operations	12.12%-5.82M	-26.76%-5.61M	-19.71%-6.14M	-63.47%-19.58M	33.27%-3.4M	-162.95%-6.62M	-41.31%-4.42M	-316.50%-5.13M	-43.57%-11.98M	-35.12%-5.1M
Operating gains losses	238.24%115K	-183.21%-388K	99.43%-3K	-185.13%-1.02M	-126.89%-388.2K	102.96%34K	-115.28%-137K	-23,725.41%-524K	6,373.96%1.19M	--1.44M
Depreciation and amortization	50.00%3K	--0	-50.00%1K	164.10%13.94K	396.50%7.94K	-7.80%2K	159.78%2K	170.52%2K	-97.87%5.28K	-85.97%1.6K
Asset impairment expenditure	----	----	----	--2.76M	---145.09K	----	----	----	--0	--0
Remuneration paid in stock	377.78%774K	60.38%834K	15.47%642K	-9.95%1.47M	-64.91%234.28K	-69.81%162K	84.22%520K	274.15%556K	54.10%1.64M	251.13%667.6K
Other non cashItems	----	----	----	-354.85%-340.02K	--12.98K	---39K	---121K	---193K	229.34%133.42K	----
Change In working capital	149.38%803K	370.34%319K	-703.88%-1.87M	-356.76%-714.19K	-187.33%-686.19K	-1.52%322K	88.60%-118K	-215.79%-232K	-61.91%278.15K	37.32%785.77K
-Change in receivables	-103.10%-18K	309.72%151K	144.55%98K	87.69%-29.96K	-83.17%-317.96K	14,179.98%580K	67.10%-72K	-251.82%-220K	-223.76%-243.48K	-395.02%-173.59K
-Change in prepaid assets	140.26%31K	164.65%128K	-2,464.29%-1.08M	-2,038.66%-1.64M	-2,258.14%-1.33M	-72.08%-77K	-1,462.14%-198K	-536.99%-42K	-5,117.64%-76.89K	-692.85%-56.29K
-Change in payables and accrued expense	536.46%790K	-73.68%40K	-3,053.33%-886K	60.42%960.15K	-5.56%959.15K	-149.23%-181K	118.30%152K	-34.55%30K	11.89%598.52K	69.90%1.02M
Cash from discontinued investing activities
Operating cash flow	-27.42%-4.13M	-13.21%-4.84M	-33.42%-7.37M	-99.27%-17.4M	-111.48%-4.36M	-13.77%-3.24M	-45.36%-4.28M	-527.54%-5.52M	-104.95%-8.73M	-115.93%-2.06M
Investing cash flow
Cash flow from continuing investing activities	-218.17%-15.33M	325.94%8.47M	0	133.40%4.42M	30.51%-9.18M	179,689.44%12.97M	37,754.90%1.99M	-1.37M	-597,984.67%-13.22M	-78,723,875.03%-13.21M
Net PPE purchase and sale	---3K	0.00%-3K	--0	69.19%-4.18K	82.99%-180.6311	--0	43.21%-3K	---1K	-513.84%-13.57K	-6,230.48%-1.06K
Net investment purchase and sale	-218.15%-15.33M	325.45%8.48M	--0	133.47%4.42M	30.51%-9.18M	--12.97M	--1.99M	---1.37M	---13.21M	---13.21M
Cash from discontinued investing activities
Investing cash flow	-218.17%-15.33M	325.94%8.47M	--0	133.40%4.42M	30.51%-9.18M	179,689.44%12.97M	37,754.90%1.99M	---1.37M	-597,984.67%-13.22M	-78,723,875.03%-13.21M
Financing cash flow
Cash flow from continuing financing activities	311.76%700K	11,500.00%1.39M	2K	-2.31%37.27M	6,044.41%37.08M	106.83%170K	-99.97%12K	0	1,765.70%38.15M	5,703.15%603.55K
Net issuance payments of debt	----	----	----	--0	--0	--0	--0	--0	---284.94K	---76.01K
Net common stock issuance	----	----	----	21.87%29.82M	4,966.10%29.82M	--0	----	----	1,096.82%24.47M	5,560.15%588.68K
Proceeds from stock option exercised by employees	311.76%700K	11,500.00%1.39M	--2K	-46.17%7.44M	2,082.96%7.26M	148.97%170K	--12K	--0	--13.83M	--332.65K
Cash from discontinued financing activities
Financing cash flow	311.76%700K	11,500.00%1.39M	--2K	-1.96%37.27M	7,788.20%37.08M	106.83%170K	-99.97%12K	--0	1,759.18%38.01M	4,420.28%470.13K
Net cash flow
Beginning cash position	434.35%38.22M	238.11%32.71M	140.23%40.07M	960.15%15.38M	-46.68%17.36M	-80.55%7.15M	338.55%9.68M	1,072.70%16.68M	-59.59%1.45M	1,322.31%32.56M
Current changes in cash	-289.36%-18.76M	320.51%5.02M	-6.88%-7.36M	51.18%24.28M	259.05%23.54M	285.41%9.91M	-106.43%-2.28M	-977.53%-6.89M	859.23%16.06M	-1,657.22%-14.8M
Effect of exchange rate changes	-150.82%-155K	296.75%484K	102.59%3K	159.13%518.4K	149.51%575.4K	-73.99%305K	72.23%-246K	-7,745.08%-116K	-1,465.56%-876.68K	-1,948.55%-1.16M
End cash Position	11.18%19.3M	434.35%38.22M	238.11%32.71M	141.52%40.18M	141.52%40.18M	-46.68%17.36M	-80.55%7.15M	338.55%9.68M	1,073.39%16.63M	1,073.39%16.63M
Free cash from	-27.52%-4.13M	-13.20%-4.85M	-33.39%-7.37M	-99.01%-17.41M	-111.38%-4.37M	-13.48%-3.24M	-45.20%-4.28M	-527.65%-5.52M	-105.16%-8.75M	-116.03%-2.07M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Amidst the global market turbulence triggered by the US-Europe dispute over Greenland, a single post by Trump instantly reversed market tren Show More

Futubull Options Sir

Jan 19 17:47

Options Weekly 0119 | Greenland tariff standoff, gold and silver surge again, shocking reversal in Fed chair nominee! Watch Intel, Netflix earnings reports

杨杨得億

Jan 20 13:42

The real danger in the 2026 market isn't black swan events, but rather the changes you've become accustomed to ignoring.